BE635889A - - Google Patents

Info

Publication number
BE635889A
BE635889A BE635889DA BE635889A BE 635889 A BE635889 A BE 635889A BE 635889D A BE635889D A BE 635889DA BE 635889 A BE635889 A BE 635889A
Authority
BE
Belgium
Prior art keywords
methyl ketone
formula
hexyl
salts
ethanol
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE635889A publication Critical patent/BE635889A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE635889D BE635889A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL296701T

Publications (1)

Publication Number Publication Date
BE635889A true BE635889A (ko)

Family

ID=19783011

Family Applications (1)

Application Number Title Priority Date Filing Date
BE635889D BE635889A (ko)

Country Status (2)

Country Link
BE (1) BE635889A (ko)
NL (1) NL296701A (ko)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49101346A (ko) * 1973-01-30 1974-09-25
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
US10130594B2 (en) 2010-03-10 2018-11-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49101346A (ko) * 1973-01-30 1974-09-25
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
JP2013224316A (ja) * 2006-08-10 2013-10-31 Usa Government (r,r)−フェノテロールおよび(r,r)−または(r,s)−フェノテロール類似体の調製物ならびにうっ血性心不全の治療におけるそれらの使用
US9908841B2 (en) 2006-08-10 2018-03-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
US10562843B2 (en) 2006-08-10 2020-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
US10130594B2 (en) 2010-03-10 2018-11-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
US10617654B2 (en) 2010-03-10 2020-04-14 The Usa, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
US10925840B2 (en) 2010-03-10 2021-02-23 The Usa, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Also Published As

Publication number Publication date
NL296701A (ko)

Similar Documents

Publication Publication Date Title
EP0040591B1 (fr) Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique
EP0370901A1 (fr) Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant
EP0009445B1 (fr) Procédé de préparation d'hydroxy-9 ellipticine et de dérivés de celle-ci
CH671574A5 (ko)
EP0004493B1 (fr) Nouveaux éthers dont les restes organiques comportent des atomes chiraux, leur procédé de préparation et leur application au dédoublement des alcools, des phénols ou de certains composés de structure lactonique
EP0025727B1 (fr) Dérivés de l'indole, procédé pour leur préparation et médicaments les contenant
CH641181A5 (fr) Indolo-quinolizidines, procede pour leur preparation et compositions therapeutiques les contenant.
EP0376850B1 (fr) Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant
EP0028959B1 (fr) Dérivés de la 5,8,13,13a-tétrahydro-6H-dibenzo (a,g) quinolizine, procédé d'obtention et compositions pharmaceutiques les contenant
EP0053964B1 (fr) Médicaments à base de dérivés de (quinolyl-4)-1 éthanol ou propanol, nouveaux dérivés de (quinolyl-4)-1 éthanol ou propanol et procédés pour leur préparation
BE635889A (ko)
EP0001021B1 (fr) Nouveaux dérivés d'alcaloides pentacycliques, procédé de préparation, application à la synthèse de produits du groupe de l'éburnamonine et compositions pharmaceutiques
EP0074873B1 (fr) Dérivés de phénoxy-3 propanol-2, leur préparation et leur application en thérapeutique
EP0269599A2 (fr) 1H-Imidazoles substitués
EP0251938B1 (fr) Procédé de synthèse stéréospécifique de dérivés de l'indole
EP0842148B1 (fr) Derives de benzenesulfonamide, leur preparation et leurs applications en therapeutique
EP0303545B1 (fr) Procédé pour la préparation de phényléthanolaminotétralines
EP0327455A1 (fr) Ethers alkyliques ou benzyliques du phénol, leurs procédés de préparation et leur application en thérapeutique
EP0500443A1 (fr) Nouvelles phényléthanolamino- et phényléthanolaminométhyl-tétralines, procédé pour leur préparation, intermédiaires dans ce procédé et compositions pharmaceutiques les contenant
EP0143711B1 (fr) Dérivés de N-(méthoxyphénacyl)-amine, utilisation notamment en thérapeutique et procédé de préparation
CH644355A5 (fr) Derives de 1-phenyl-1-propanol.
EP0065907B1 (fr) ((Tétra- et hexahydro pyridyl-4)-2 éthyl)-3 indoles et leur utilisation comme médicaments
CH638183A5 (fr) Derives de pyrrolidine et de piperidine.
FR2560873A1 (fr) Medicaments a base de derives de la piperidine, nouveaux derives de la piperidine et leurs procedes de preparation
FR2500454A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments